Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Cancer led to the deaths of more than 9 million people worldwide in 2018, and most of these deaths were due to metastatic tumor burden. While in most cases, we still do not know why cancer is lethal, we know that a total tumor burden of 1 kg—equivalent to one trillion cells—is not compatible with life. While localized disease is curable through surgical removal or radiation, once cancer has spread, it is largely incurable. The inability to cure metastatic cancer lies, at least in part, to the fact that cancer is resistant to all known compounds and anticancer drugs. The source of this resistance remains undefined. In fact, the vast majority of metastatic cancers are resistant to all currently available anticancer therapies, including chemotherapy, hormone therapy, immunotherapy, and systemic radiation. Thus, despite decades—even centuries—of research, metastatic cancer remains lethal and incurable. We present historical and contemporary evidence that the key actuators of this process—of tumorigenesis, metastasis, and therapy resistance—are polyploid giant cancer cells.

Original languageEnglish (US)
Pages (from-to)1489-1497
Number of pages9
JournalProstate
Volume79
Issue number13
DOIs
StatePublished - Jan 1 2019

Fingerprint

Polyploidy
Giant Cells
Carcinogenesis
Neoplasm Metastasis
Neoplasms
Tumor Burden
Radiation
Immunotherapy
Therapeutics
Hormones
Drug Therapy
Research

All Science Journal Classification (ASJC) codes

  • Urology
  • Oncology

Keywords

  • cancer ecology
  • keystone species
  • metastasis
  • polyploid giant cancer cells
  • stemness
  • therapeutic resistance

Cite this

@article{f66bffce12b046b3ad206f004ae0bf0d,
title = "Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance",
abstract = "Cancer led to the deaths of more than 9 million people worldwide in 2018, and most of these deaths were due to metastatic tumor burden. While in most cases, we still do not know why cancer is lethal, we know that a total tumor burden of 1 kg—equivalent to one trillion cells—is not compatible with life. While localized disease is curable through surgical removal or radiation, once cancer has spread, it is largely incurable. The inability to cure metastatic cancer lies, at least in part, to the fact that cancer is resistant to all known compounds and anticancer drugs. The source of this resistance remains undefined. In fact, the vast majority of metastatic cancers are resistant to all currently available anticancer therapies, including chemotherapy, hormone therapy, immunotherapy, and systemic radiation. Thus, despite decades—even centuries—of research, metastatic cancer remains lethal and incurable. We present historical and contemporary evidence that the key actuators of this process—of tumorigenesis, metastasis, and therapy resistance—are polyploid giant cancer cells.",
keywords = "cancer ecology, keystone species, metastasis, polyploid giant cancer cells, stemness, therapeutic resistance",
author = "Austin, {Robert H.}",
year = "2019",
month = "1",
day = "1",
doi = "https://doi.org/10.1002/pros.23877",
language = "English (US)",
volume = "79",
pages = "1489--1497",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "13",

}

Polyploid giant cancer cells : Unrecognized actuators of tumorigenesis, metastasis, and resistance. / Austin, Robert H.

In: Prostate, Vol. 79, No. 13, 01.01.2019, p. 1489-1497.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Polyploid giant cancer cells

T2 - Unrecognized actuators of tumorigenesis, metastasis, and resistance

AU - Austin, Robert H.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Cancer led to the deaths of more than 9 million people worldwide in 2018, and most of these deaths were due to metastatic tumor burden. While in most cases, we still do not know why cancer is lethal, we know that a total tumor burden of 1 kg—equivalent to one trillion cells—is not compatible with life. While localized disease is curable through surgical removal or radiation, once cancer has spread, it is largely incurable. The inability to cure metastatic cancer lies, at least in part, to the fact that cancer is resistant to all known compounds and anticancer drugs. The source of this resistance remains undefined. In fact, the vast majority of metastatic cancers are resistant to all currently available anticancer therapies, including chemotherapy, hormone therapy, immunotherapy, and systemic radiation. Thus, despite decades—even centuries—of research, metastatic cancer remains lethal and incurable. We present historical and contemporary evidence that the key actuators of this process—of tumorigenesis, metastasis, and therapy resistance—are polyploid giant cancer cells.

AB - Cancer led to the deaths of more than 9 million people worldwide in 2018, and most of these deaths were due to metastatic tumor burden. While in most cases, we still do not know why cancer is lethal, we know that a total tumor burden of 1 kg—equivalent to one trillion cells—is not compatible with life. While localized disease is curable through surgical removal or radiation, once cancer has spread, it is largely incurable. The inability to cure metastatic cancer lies, at least in part, to the fact that cancer is resistant to all known compounds and anticancer drugs. The source of this resistance remains undefined. In fact, the vast majority of metastatic cancers are resistant to all currently available anticancer therapies, including chemotherapy, hormone therapy, immunotherapy, and systemic radiation. Thus, despite decades—even centuries—of research, metastatic cancer remains lethal and incurable. We present historical and contemporary evidence that the key actuators of this process—of tumorigenesis, metastasis, and therapy resistance—are polyploid giant cancer cells.

KW - cancer ecology

KW - keystone species

KW - metastasis

KW - polyploid giant cancer cells

KW - stemness

KW - therapeutic resistance

UR - http://www.scopus.com/inward/record.url?scp=85070077596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070077596&partnerID=8YFLogxK

U2 - https://doi.org/10.1002/pros.23877

DO - https://doi.org/10.1002/pros.23877

M3 - Review article

C2 - 31376205

VL - 79

SP - 1489

EP - 1497

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 13

ER -